Publication | Open Access

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study

OncologyMetronomic TherapyPharmacologyPhase Iii TrialTriple StudyPalonosetron Versus GranisetronPharmacotherapyMetronomic ChemotherapyMedicine